No Data
No Data
Allakos Inc.: Hold Rating Amid Restructuring and Financial Uncertainty
Allakos GAAP EPS of $0.00
Allakos | 10-K: FY2024 Annual Report
Allakos | 8-K: Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
Express News | Allakos Q4 Net Income USD 376 Thousand
Express News | Allakos Q4 Operating Expenses USD 773 Thousand
Nitram74 : ok
Diaper Fund 4 MyGirl : Thank you
Bigdaddy Crypto :


Arrayfunction : Do you know much about $Nexalin Technology (NXL.US)$ 's tech? It's one of those I wish would work out but I am getting too many red flags. The tech just sounds like deep brain stimulation - which has never been shown to be effective enough for indication. The head scratcher about why a 2mmHg decrease in BP is a success when that's within margin of error for most devices. Also, it didn't reference that norepinephrine and dopamine are given in all kinds of MDD / chronic pain situations which will raise BP.
I could certainly use an anti-hypertensive. My MAP tends to chill at about 115mmHg these days. But don't want to get my hopes up
SunTzu lead Arrayfunction : dont ask about other stocks wirh jag
View more comments...